在武汉一家发热门诊的新型冠状病毒感染患者中观察到“白细胞*淋巴细胞”减少。 - Suppr | 超能文献

相似文献

1

Decreased "WBC*LYM" was observed in SARS-CoV-2-infected patients from a fever clinic in Wuhan.在武汉一家发热门诊的新型冠状病毒感染患者中观察到“白细胞*淋巴细胞”减少。

Clin Chem Lab Med. 2020 Jun 25;58(7):1152-1155. doi: 10.1515/cclm-2020-0270.

2

Evaluations of the serological test in the diagnosis of 2019 novel coronavirus (SARS-CoV-2) infections during the COVID-19 outbreak.新型冠状病毒（SARS-CoV-2）感染的血清学检测在 COVID-19 疫情期间的诊断评估。

Eur J Clin Microbiol Infect Dis. 2020 Dec;39(12):2271-2277. doi: 10.1007/s10096-020-03978-6. Epub 2020 Jul 17.

3

Neutrophil-to-lymphocyte ratio predicts the clearance of SARS-CoV-2 RNA in mild COVID-19 patients - a retrospective analysis from Dongxihu Fangcang Hospital in Wuhan, China.中性粒细胞与淋巴细胞比值可预测轻型新型冠状病毒肺炎患者新冠病毒RNA的清除情况——来自中国武汉东西湖方舱医院的一项回顾性分析

Clin Chem Lab Med. 2020 Jul 1;58(9):e167-e170. doi: 10.1515/cclm-2020-0733. Print 2020 Aug 27.

4

The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.初步筛查和诊断的意义：中国湖南 33 例 SARS-CoV-2 感染轻症患者的临床特征。

J Clin Virol. 2020 Jul;128:104397. doi: 10.1016/j.jcv.2020.104397. Epub 2020 Apr 30.

5

Clinical Characteristics of Patients with Severe Pneumonia Caused by the SARS-CoV-2 in Wuhan, China.中国武汉严重肺炎患者的临床特征。

Respiration. 2020;99(8):649-657. doi: 10.1159/000507940. Epub 2020 Aug 25.

6

Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China.中国武汉 140 名 SARS-CoV-2 感染患者的临床特征。

Allergy. 2020 Jul;75(7):1730-1741. doi: 10.1111/all.14238. Epub 2020 Feb 27.

7

Infection with SARS-CoV-2 causes abnormal laboratory results of multiple organs in patients.感染新型冠状病毒严重急性呼吸综合征冠状病毒2（SARS-CoV-2）会导致患者多个器官的实验室检查结果异常。

Aging (Albany NY). 2020 Jun 1;12(11):10059-10069. doi: 10.18632/aging.103255.

8

A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.回顾性研究 2020 年 1 月至 3 月中国武汉 108 例早期 COVID-19 肺炎患者 C 反应蛋白与淋巴细胞比值与疾病严重程度的关系

Med Sci Monit. 2020 Sep 11;26:e926393. doi: 10.12659/MSM.926393.

9

The hemocyte counts as a potential biomarker for predicting disease progression in COVID-19: a retrospective study.血细胞计数作为预测 COVID-19 疾病进展的潜在生物标志物：一项回顾性研究。

Clin Chem Lab Med. 2020 Jun 25;58(7):1106-1115. doi: 10.1515/cclm-2020-0377.

10

Clinical characteristics of coronavirus disease 2019 in Gansu province, China.中国甘肃省2019冠状病毒病的临床特征

Ann Palliat Med. 2020 Jul;9(4):1404-1412. doi: 10.21037/apm-20-887. Epub 2020 Jul 13.

引用本文的文献

1

"Lymphocyte * Neutrophil" count decreased in SARS-CoV-2 Omicron patients in Shanghai with no significant change in CRP and SAA.上海 SARS-CoV-2 奥密克戎感染者淋巴细胞与中性粒细胞计数下降，C 反应蛋白和血清淀粉样蛋白 A 无明显变化。

J Clin Lab Anal. 2022 Oct;36(10):e24671. doi: 10.1002/jcla.24671. Epub 2022 Aug 21.

2

Definition of the Immune Parameters Related to COVID-19 Severity.与 COVID-19 严重程度相关的免疫参数的定义。

Front Immunol. 2022 Mar 18;13:850846. doi: 10.3389/fimmu.2022.850846. eCollection 2022.

3

A Retrospective Study of the C-Reactive Protein to Lymphocyte Ratio and Disease Severity in 108 Patients with Early COVID-19 Pneumonia from January to March 2020 in Wuhan, China.